Skip to content

Defocused Shock Wave Therapy for Chronic Wounds

Defocused Shock Wave Therapy for Chronic Soft Tissue Wounds of the Lower Limbs. A Pilot Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02410447
Enrollment
10
Registered
2015-04-07
Start date
2012-05-31
Completion date
2015-03-31
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds

Keywords

Shock waves

Brief summary

Chronic soft tissue wounds of the lower limbs are painful and debilitating condition that significantly reduce the quality of life of the patient. They often do not respond to conservative treatments or advanced wound managements. Focused and defocused extracorporeal shock wave therapy can be a viable alternative therapeutic strategy. The purpose of the study was to examine the effects of defocused extracorporeal shock wave treatment on chronic soft tissue wounds of the lower limbs, in terms of the rate of wound healing and pain control.

Interventions

DEVICEDefocused shock wave therapy (DUOLITH® SD1)

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chronic post-traumatic, venous, arterial, diabetic, or mixed wound of the lower limb * wound persisting for longer than three months * a wound surface bigger than 0,5 cm2 * a wound diameter between 0.5 and 5 cm * unresponsiveness to conservative treatments and advanced wound managements in the 3 months prior to enrollment * no changes in wound managements during the study.

Exclusion criteria

* an ankle brachial index (ABPI)\<0.7 and TcPO2\<40 mmHg * arrhythmias, presence of pacemaker, or coagulation disorders * use of anticoagulant drugs * neoplasia * pregnancy * soft tissue wound infections and/or osteomyelitis * patients with full-thickness loss of soft tissue and extension into muscle, bone, tendon, or joint capsule.

Design outcomes

Primary

MeasureTime frameDescription
Changes from baseline of the wound surface15 days, 1 month and 3 months after treatmentComputerized digital photo documentation was used to define the size of the wound with a specific software

Secondary

MeasureTime frameDescription
Changes from baseline of the wound characteristic15 days, 1 month and 3 months after treatmentWounds characteristics were assessed by the Bates-Jensen Wound Assessment Tool
Improvement in subjective wound-related pain intensity15 days, 1 month and 3 months after treatmentSubjective wound-related pain was evaluated using the Visual Analogue Score

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026